Liquid biopsy in breast cancer Eva Valentina KlockerChristoph Suppan short review Open access 23 April 2024
Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor Petar PopovOskar SteinbrecherWolfgang Lamm case report Open access 22 April 2024
American Society of Hematology (ASH) update 2023—chronic lymphocytic leukemia Thomas Nösslinger short review 18 April 2024
The future of clinical trials—goals, ideas, and discussion Michael GnantManuela GiliHannes Fohler review Open access 18 April 2024
15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives Peter ValentEmir HadzijusufovicGregor Hoermann review Open access 26 March 2024
Treatment-changing news in urogenital cancer—a brief unstructured narrative review based on findings presented at the ESMO 2023 conference Alexander Jakob ZgubicMarianne LeitsmannMartin Pichler short review Open access 18 March 2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology Abstracts OeGHO / AHOP 13 March 2024 Pages: 1 - 36
Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma Changbin WangRan ZhangLigang Xing original report 28 February 2024
Seminal vesicle metastasis from transverse colon adenocarcinoma: a unique case report Juliana Arenas HoyosJulian Serrano GiraldoAndres Felipe Gutierrez Rojas case report Open access 23 February 2024
β-adrenergic modulation of IL-6/gp130 and SOCS-1 in multiple myeloma: therapeutic strategy for stress induced-inflammatory response Raika NaiebiSaeid AbrounMorvarid Siri original report 09 February 2024
Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations Yana SharapovaSonja LogesMelanie Janning short review Open access 08 February 2024
“Navigating the evolving landscape of cancer treatment: a triad of progress” Andreas Pircher editorial 06 February 2024 Pages: 1 - 1
Innovative therapeutic concepts for biliary tumors Angela Djanani short review Open access 29 January 2024 Pages: 20 - 25
Can artificial intelligence provide accurate and reliable answers to cancer patients’ questions about cancer pain? Comparison of chatbots based on ESMO cancer pain guideline Kadriye Bir YücelOsman SutcuogluNuriye Ozdemir original report 26 January 2024
Antibody–drug conjugates in ovarian cancer Barin FerozChristian MarthAlain Gustave Zeimet short review Open access 25 January 2024
Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule Theresa LentnerGerhard Krajnik case report Open access 23 January 2024 Pages: 67 - 70
(Neo)adjuvant approaches in lung cancer—paving the road to a cure Romana WassMaximilian HochmairBernd Lamprecht short review Open access 19 January 2024 Pages: 10 - 14
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review Stephan BrönimannNirmish SinglaShahrokh F Shariat short review Open access 16 January 2024 Pages: 40 - 44
Pulmonary puzzles: salivary gland-type tumors of the lung and their metastatic equivalents Gheorghe-Emilian OlteanuLuka Brcic short review Open access 11 January 2024
Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report Nino Rafael MüserKlaus KirchbacherGeorg-Christian Funk case report 08 January 2024
Molecular typing—new targets and therapy options for upper GI carcinomas with a focus on adenocarcinomas of the esophagus, gastroesophageal junction, and stomach Katja Schmitz short review 05 January 2024 Pages: 26 - 29
Metastasis-directed therapy: new standard or too early to change paradigm? Jakob KlemmPawel RajwaShahrokh F. Shariat short review Open access 29 December 2023 Pages: 45 - 50
Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence Aysegül Ilhan-MutluElisabeth Sophie Bergen short review Open access 29 December 2023
Total neoadjuvant therapy for each locally advanced rectal cancer? Gudrun Piringer short review Open access 28 December 2023 Pages: 15 - 19
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer Eva Valentina Klocker short review Open access 19 December 2023 Pages: 6 - 9
Management of oligometastatic prostate cancer Marcin MiszczykAleksander SlusarczykPaweł Rajwa short review 18 December 2023 Pages: 35 - 39
Diagnosis and management of mediastinal extragonadal germ cell tumors Axel HeidenreichPia PaffenholzDavid Pfister short review Open access 18 December 2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain Congress Report ESMO 2023 12 December 2023 Pages: 181 - 196
A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA Congress Report iwCLL 2023 12 December 2023 Pages: 163 - 179
Cancer of unknown primary—state of the art Thorsten Fuereder short review Open access 05 December 2023 Pages: 30 - 34
Emerging treatment strategies in chronic B-cell malignancies—News from ICML 2023 Jan-Paul Bohn short review Open access 05 December 2023
ASCO 2023—partnering with patients: the cornerstone of cancer care and research Gabriel Rinnerthaler editorial 04 December 2023 Pages: 215 - 216
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna Congress Report EANM 2023 01 December 2023 Pages: 143 - 161
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023 Congress Report ASH 2023 12 March 2024 Pages: 197 - 225
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress Congress Report WCLC 2023 28 November 2023 Pages: 125 - 142
Decitabine combined with low-dose cytarabine, aclarubicin and rhG-CSF regimen may be a potential alternative for relapsed/refractory acute myeloid leukemia: A single-center study Yu FuLong SuYehui Tan original report 20 November 2023
Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer Patrick ReimannThomas Winder short review 13 November 2023 Pages: 225 - 229
Focal therapy in intermediate- and high-risk prostate cancer Nicolai A. HuebnerStephan KornShahrokh F. Shariat short review Open access 10 November 2023 Pages: 247 - 250
Renal crystal-storing histiocytosis successfully treated with bortezomib-based regimen Poornima TadkalSiddini VishwanathMallikarjun Kalashetty case report 07 November 2023 Pages: 57 - 62
Management of malignant hypercalcemia in cancer patients—a short review Clemens PetraschPetra MaricsThomas Spanberger short review 03 November 2023 Pages: 263 - 267
Genetic testing and management of prostate cancer patients with pathogenic germline variants Katharina ReiterMelanie R. Hassler short review Open access 03 November 2023 Pages: 51 - 56
Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction Sophie Roider-SchurSybille MachatLeopold Öhler case report 27 October 2023 Pages: 242 - 245
